Pfizer says its vaccine is 95% effective, will apply to FDA for emergency use 'within days'
The company could have 50 million doses ready before January
Pfizer Inc. said Wednesday that its coronavirus vaccine is 95% effective and does not cause any serious side effects following injection.
The data, which comes from the company's first complete set of results following its Phase 3 trial, indicates that the vaccine prevents mild and serious forms of the novel illness and is 94% effective in elderly patients, who are more susceptible to serious forms of the virus.
The company says it plans to apply to the Food and Drug Administration for emergency use authorization "within days."
If the FDA approves the two-dose vaccine, Pfizer says it may be able to produce as many as 50 million doses by the end of 2020, and up to 1.3 billion by the end of the following year.
News, Not Noise
- Whistleblowers allege ballots illegally crossed state lines, ballot backdating, digital manipulation
- Project Veritas claims it has been secretly recording CNN's Jeff Zucker executive calls
- CEO of oilfield service business predicts Biden administration will be a boon to oil investors
- Trump demands social media giants' liability shield be scrapped, threatens defense bill veto
- Judge allows Trump campaign attorneys to review tests of Clark County voting equipment